Master studentDepartment of Clinical Laboratory Science and Medical Biotechnology, National Taiwan UniversityTaipei, Taipei, Taiwan (Republic of China)
OC 41.5 - Evaluation of factor VIII inhibitor risk under emicizumab prophylaxis using hemophilia A murine models with long-term expression of human factors IX and X
Monday, June 24, 202415:45 – 16:00 ICT